Cat. No.: DIA-0230199
Product Information | |
---|---|
CAS No. | 459147-39-8 |
Formula | C21H20N2OS3 |
Molecular Weight | 412.59 |
SMILES | CCCC[S](=O)C1=C(N)C2=C(C=C(N=C2S1)C3=CC=CS3)C4=CC=CC=C4 |
Target | 15-hydroxyprostaglandin dehydrogenase (15-PGDH) |
Product Description | SW033291 is a selective inhibitor of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) with IC50 and Kiapp of 1.5 nM and 0.1 nM, respectively. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.